BeStock  
Stocks › ABCL

AbCellera Biologics ABCL

US equityMarket cap rank #2192AI medical concept stocks
$13.78 +$0.04 (+0.29%)
Market closed · Oct 6, 2:00 am ET · Last extended-hours $13.86 +0.56%
Open$13.72
Prev close$13.74
Day range$13.21 – $13.88
Volume4.08M
Market cap$4.47B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts9
Average target$16.63+20.7% vs. price
  • Buy 89%
  • Hold 11%
Low $9.00Now $13.78Avg $16.63High $30.00

Recent rating changes

The last 20 actions on file set price targets from $7.00 to $30.00, averaging $15.78.

DateFirmRatingTarget
29 Sep 2026 J.P. Morgan BUY $17.00
27 Sep 2026 JonesTrading BUY $25.00
24 Sep 2026 Goldman Sachs HOLD $13.00
2 Sep 2026 Truist Financial BUY $30.00
17 Aug 2026 BMO Capital BUY $15.00
11 Aug 2026 Truist Financial BUY $30.00
10 Aug 2026 JonesTrading BUY $25.00
10 Aug 2026 Truist Financial BUY –
10 Aug 2026 BMO Capital BUY $15.00
7 Aug 2026 Piper Sandler BUY $12.00
6 Aug 2026 Stifel BUY $9.00
5 Aug 2026 TD Cowen BUY –
5 Aug 2026 Cantor Fitzgerald BUY $12.00
31 Jul 2026 Piper Sandler BUY $12.00
29 Jul 2026 JonesTrading BUY $13.00
16 Jul 2026 Cantor Fitzgerald BUY $11.00
15 Jul 2026 JonesTrading BUY $13.00
25 Jun 2026 JonesTrading BUY $13.00
17 Jun 2026 BMO Capital BUY $7.00
22 May 2026 Truist Financial BUY $12.00

Discussion

No comments yet — be the first to weigh in on ABCL.

Leave a comment

Scroll to Top